Join our daily newsletter At The Bell to receive exclusive market insights
The existing SaaS relationship between Knosys (ASX:KNO) and Healthdirect has been extended by a further two years. Knosys’s “market leading knowledge management platform” KnowledgeIQ will be used by Healthdirect into early 2027.
Of foremost interest to Knosys has always been Healthdirect’s governance relationships – it’s partially funded by Canberra.
Healthdirect manages a number of helplines, oversees a national health services directory, and manages a number of point of call health websites.
In September, the company inked a five-year deal with the Western Australian prosecutors’ office for KnowledgeIQ. It already has a deal with that of Victoria’s too.
The software is used, particularly, in call centres – per a scan of the company’s blog for the product, and, a look at its customer lists. On top of that, it lists insurance, manufacturing and financial customers too.
Amidst progress with winning new clients, one year returns in the stock price are up 11% – but the share price is still well-off its COVID-era highs where, as for many remote tech companies, valuations were dramatically higher.
That could remain the case for a while, given according to a service that ports Morningstar data, no shares have traded in Knosys on Thursday as at 11.40am AEDT.
KNO last traded at 4cps.
Join the discussion: See what HotCopper users are saying about Knosys and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
